Everett Harris & Co’s West Pharmaceutical WST Stock Holding History

Everett Harris & Co’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.07M	Hold	2,982	–	–	0.01%	155
2026 Q1	$747K	Hold	2,982	–	–	0.01%	186
2025 Q4	$820K	Sell	2,982 -275	-8%	-$75.2K	0.01%	181
2025 Q3	$854K	Hold	3,257	–	–	0.01%	175
2025 Q2	$713K	Hold	3,257	–	–	0.01%	192
2025 Q1	$729K	Hold	3,257	–	–	0.01%	175
2024 Q4	$1.07M	Sell	3,257 -100	-3%	-$31.5K	0.01%	133
2024 Q3	$1.01M	Hold	3,357	–	–	0.01%	137
2024 Q2	$1.11M	Sell	3,357 -400	-11%	-$141K	0.01%	126
2024 Q1	$1.49M	Hold	3,757	–	–	0.02%	115
2023 Q4	$1.32M	Sell	3,757 -50	-1%	-$17.7K	0.02%	116
2023 Q3	$1.43M	Hold	3,807	–	–	0.02%	109
2023 Q2	$1.46M	Hold	3,807	–	–	0.02%	113
2023 Q1	$1.32M	Sell	3,807 -100	-3%	-$29.2K	0.02%	117
2022 Q4	$920K	Hold	3,907	–	–	0.02%	134
2022 Q3	$961K	Hold	3,907	–	–	0.02%	127
2022 Q2	$1.18M	Hold	3,907	–	–	0.02%	126
2022 Q1	$1.6M	Hold	3,907	–	–	0.02%	110
2021 Q4	$1.83M	Hold	3,907	–	–	0.03%	104
2021 Q3	$1.66M	Hold	3,907	–	–	0.03%	107
2021 Q2	$1.4M	Hold	3,907	–	–	0.02%	122
2021 Q1	$1.1M	Hold	3,907	–	–	0.02%	130
2020 Q4	$1.11M	Hold	3,907	–	–	0.02%	124
2020 Q3	$1.07M	Hold	3,907	–	–	0.02%	119
2020 Q2	$888K	Buy	+3,907	New	+$768K	0.02%	127

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Everett Harris & Co's WST Position: Q2 2026 in Review

Everett Harris & Co held its West Pharmaceutical (WST) position steady in Q2 2026 at 2,982 shares worth $1.07M. The position accounts for 0.01% of the portfolio, ranked #155.

Everett Harris & Co first reported a position in WST in Q2 2020 and has held it in 25 quarters since. The position peaked at $1.83M in Q4 2021. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Everett Harris & Co held 2,982 shares of West Pharmaceutical worth $1.07M as of Q2 2026.
Everett Harris & Co left its West Pharmaceutical share count unchanged in Q2 2026.
West Pharmaceutical made up 0.01% of Everett Harris & Co's portfolio in Q2 2026, its #155 holding.
Everett Harris & Co first reported a position in West Pharmaceutical in Q2 2020 and has held it in 25 quarters since.
Everett Harris & Co's West Pharmaceutical position peaked at $1.83M in Q4 2021.
830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Everett Harris & Co's 13F filing for Q2 2026, filed 3 Aug 2026.